GlassScriptPhysician profile
Syed M Quadri
NPI 1992926307
$9,467.82
in general payments reported to CMS, 2019-2025
46 companies · $1,155 in 2025
The $1,155 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,365 · 2020: $1,227 · 2021: $1,411 · 2022: $1,248 · 2023: $1,505 · 2024: $1,555 · 2025: $1,155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,215.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,298.84 | 2019-2025 | Proclaim, Eterna, Freestyle Libre 3 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,211.26 | 2019-2025 | Relistor, Trulance |
| Abbvie INC. | $900.09 | 2021-2025 | |
| Collegium Pharmaceutical, INC. | $632.52 | 2019-2025 | Belbuca, Xtampza, Jornay Pm |
| Pfizer INC. | $368.79 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $349.30 | 2019-2021 | |
| Medtronic, INC. | $315.41 | 2021-2025 | Inceptiv |
| Medtronic USA, INC. | $280.44 | 2019-2020 | |
| Lilly USA, LLC | $280.25 | 2019-2025 | Emgality, Reyvow, Zepbound |
| Nalu Medical, INC. | $275.93 | 2024 | Nalu Neurostimulation System |
| Amgen INC. | $241.60 | 2019-2023 | Evenity, Prolia |
| Scilex Pharmaceuticals INC. | $238.28 | 2019-2024 | |
| Teva Pharmaceuticals USA, INC. | $209.57 | 2019-2022 | |
| Lundbeck LLC | $185.97 | 2021-2024 | Vyepti |
| Almatica Pharma LLC | $153.39 | 2021 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Syed Quadri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.